Valeant Pharmaceuticals is to acquire OraPharma, a specialty oral health company that develops and commercialises products that improve and maintain oral health, from Water Street Healthcare Partners, a private equity firm focused exclusively on the health care industry. Total consideration is approximately USD312 million and up to USD114 million in

Munich-based venture capital firm Target Partners has made a seven-figure investment in doo GmbH (www.doo.net). doo’s main objective is to make the paperless office a reality by means of a cloud-based platform that organises documents intelligently. Equipped with apps for the relevant operating systems, doo is geared toward consumers and

In a review of 1,350 deals done between 2007-2011, CMS’ fourth annual M&A Study highlights some key differences in the legal provisions used in merger & acquisition agreements across Europe and the US. Thomas Meyding, Head of CMS Corporate Group, says: "2011 was a good year for sellers. The fact

Encore Capital has completed an investment into Technical Software Consultants Limited (TSC), a designer and manufacturer of non-destructive testing equipment. The transaction was supported by Octopus Investments (Octopus), which provided a GBP3m facility to enable the acquisition. Encore has acquired a majority shareholding, providing a partial exit for TSC’s two

Balance Water Inc has closed on a Series A financing round from Emil Capital Partners, Thomas H Lee and Hugh Jackman. Balance is a non-flavoured functional beverage bottled locally in California, New York, Sydney, Australia and next month in Cologne, Germany. Its point of difference is the use of wild

Norwest Equity Partners (NEP) has acquired Pentech Holdings, Inc (Pentec) from DW Healthcare Partners, Frazier Healthcare and Pentec management. Pentec is a national provider of specialty infusion services to patients who require access to complex pharmaceutical products and services outside of the hospital setting. Pentec Chairman and CEO, Joe Cosgrove,

Hipmunk has closed a USD15 million Series B financing round led by Institutional Venture Partners (IVP). Todd Chaffee (pictured), General Partner at IVP, will join Hipmunk’s board of directors. Existing angel investors and the Series A lead, Ignition Partners, also participated in the round. "IVP has a highly successful 31 year